Time to Treat: A System Redesign Focusing on Decreasing the Time from Suspicion of Lung Cancer to Diagnosis

Introduction: Multiple investigations often result in a lengthy process from the onset of lung cancer–related symptoms until diagnosis. An unpublished chart audit indicated suboptimal delays in patients' courses from onset of symptoms until diagnosis of cancer. Methods: The Time to Treat Program was designed for patients with clinical or radiographic suspicion of lung cancer. Pre- and postimplementation data on median wait times were compared. Results: From April 2005 to January 2007, 430 patients were referred. After Time to Treat Program implementation, the median time from suspicion of lung cancer to referral for specialist consultation decreased from 20 days to 6 days, and the median time from such referral to the actual consultation date decreased from 17 days to 4 days. The median time from specialist consultation to computed tomography scan decreased from 52 days to 3 days, and the median time from computed tomography scan to diagnosis decreased from 39 days to 6 days. Overall, the median time from suspicion of lung cancer to diagnosis decreased from 128 days to 20 days. Of all patients in the Time to Treat Program, 33% were eventually diagnosed with lung cancer. Conclusions: Time to Treat Program was effective in shortening the time from suspicion of lung cancer to diagnosis and reduced time intervals at each step in the process. Earlier diagnosis of lung cancer may allow increased treatment options for patients and may improve outcomes.

[1]  Y. Ichinose,et al.  Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. , 1994, The Journal of thoracic and cardiovascular surgery.

[2]  S. Aggestrup,et al.  The impact of delayed diagnosis of lung cancer on the stage at the time of operation. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  R. Coulden,et al.  Improving surgical resection rate in lung cancer , 1998, Thorax.

[4]  P. Corcoran,et al.  Impact of revised stage classification of lung cancer on survival: a military experience. , 1999, Chest.

[5]  D. Harcourt,et al.  Same-day diagnosis of symptomatic breast problems: Psychological impact and coping strategies , 1999 .

[6]  Y. Nishiwaki,et al.  Prognostic factors in clinical stage I non-small cell lung cancer. , 1999, The Annals of thoracic surgery.

[7]  K. Zahasky,et al.  A multidisciplinary healthcare delivery model for women with breast cancer: patient satisfaction and physical and psychosocial adjustment. , 1999, Oncology nursing forum.

[8]  M. Green,et al.  The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed? , 1999, Chest.

[9]  R. Dziadziuszko,et al.  Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. , 2000, The Journal of thoracic and cardiovascular surgery.

[10]  A B de la Rivière,et al.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. , 2000, Chest.

[11]  C. Woodman,et al.  Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial , 2018 .

[12]  Jeremy Hurst,et al.  Tackling Excessive Waiting Times for Elective Surgery: A Comparison of Policies in Twelve OECD Countries , 2003 .

[13]  Jeremy Hurst,et al.  Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries. , 2005, Health policy.

[14]  R. Steinbrook Private health care in Canada. , 2006, The New England journal of medicine.

[15]  J. Sampalis,et al.  Delays to surgery in non-small-cell lung cancer. , 2006, Canadian journal of surgery. Journal canadien de chirurgie.

[16]  M. Dransfield,et al.  Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System. , 2006, Clinical lung cancer.

[17]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.